The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lyophilized IVIG-Global Market Insights and Sales Trends 2025
Synopsis
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors.
The global Lyophilized IVIG market size is expected to reach US$ 246.4 million by 2029, growing at a CAGR of 7.8% from 2023 to 2029. The market is mainly driven by the significant applications of Lyophilized IVIG in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Lyophilized IVIG market. 2.5g, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1.25g segment is estimated at % CAGR for the next seven-year period.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lyophilized IVIG, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lyophilized IVIG market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lyophilized IVIG market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lyophilized IVIG sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lyophilized IVIG covered in this report include Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc.
The global Lyophilized IVIG market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Global Lyophilized IVIG market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lyophilized IVIG market, Segment by Type:
2.5g
1.25g
Global Lyophilized IVIG market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors.
The global Lyophilized IVIG market size is expected to reach US$ 246.4 million by 2029, growing at a CAGR of 7.8% from 2023 to 2029. The market is mainly driven by the significant applications of Lyophilized IVIG in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Lyophilized IVIG market. 2.5g, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1.25g segment is estimated at % CAGR for the next seven-year period.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lyophilized IVIG, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lyophilized IVIG market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lyophilized IVIG market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lyophilized IVIG sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lyophilized IVIG covered in this report include Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc.
The global Lyophilized IVIG market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Global Lyophilized IVIG market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lyophilized IVIG market, Segment by Type:
2.5g
1.25g
Global Lyophilized IVIG market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Lyophilized IVIG Market Overview
1.1 Lyophilized IVIG Product Overview
1.2 Lyophilized IVIG Market Segment by Type
1.2.1 2.5g
1.2.2 1.25g
1.3 Global Lyophilized IVIG Market Size by Type
1.3.1 Global Lyophilized IVIG Market Size Overview by Type (2018-2029)
1.3.2 Global Lyophilized IVIG Historic Market Size Review by Type (2018-2023)
1.3.3 Global Lyophilized IVIG Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lyophilized IVIG Sales Breakdown by Type (2018-2023)
1.4.2 Europe Lyophilized IVIG Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Lyophilized IVIG Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Lyophilized IVIG Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Lyophilized IVIG Sales Breakdown by Type (2018-2023)
2 Global Lyophilized IVIG Market Competition by Company
2.1 Global Top Players by Lyophilized IVIG Sales (2018-2023)
2.2 Global Top Players by Lyophilized IVIG Revenue (2018-2023)
2.3 Global Top Players by Lyophilized IVIG Price (2018-2023)
2.4 Global Top Manufacturers Lyophilized IVIG Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lyophilized IVIG Market Competitive Situation and Trends
2.5.1 Lyophilized IVIG Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Lyophilized IVIG Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lyophilized IVIG as of 2022)
2.7 Date of Key Manufacturers Enter into Lyophilized IVIG Market
2.8 Key Manufacturers Lyophilized IVIG Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lyophilized IVIG Status and Outlook by Region
3.1 Global Lyophilized IVIG Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Lyophilized IVIG Historic Market Size by Region
3.2.1 Global Lyophilized IVIG Sales in Volume by Region (2018-2023)
3.2.2 Global Lyophilized IVIG Sales in Value by Region (2018-2023)
3.2.3 Global Lyophilized IVIG Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Lyophilized IVIG Forecasted Market Size by Region
3.3.1 Global Lyophilized IVIG Sales in Volume by Region (2024-2029)
3.3.2 Global Lyophilized IVIG Sales in Value by Region (2024-2029)
3.3.3 Global Lyophilized IVIG Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Lyophilized IVIG by Application
4.1 Lyophilized IVIG Market Segment by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Lyophilized IVIG Market Size by Application
4.2.1 Global Lyophilized IVIG Market Size Overview by Application (2018-2029)
4.2.2 Global Lyophilized IVIG Historic Market Size Review by Application (2018-2023)
4.2.3 Global Lyophilized IVIG Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lyophilized IVIG Sales Breakdown by Application (2018-2023)
4.3.2 Europe Lyophilized IVIG Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Lyophilized IVIG Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Lyophilized IVIG Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Lyophilized IVIG Sales Breakdown by Application (2018-2023)
5 North America Lyophilized IVIG by Country
5.1 North America Lyophilized IVIG Historic Market Size by Country
5.1.1 North America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Lyophilized IVIG Sales in Volume by Country (2018-2023)
5.1.3 North America Lyophilized IVIG Sales in Value by Country (2018-2023)
5.2 North America Lyophilized IVIG Forecasted Market Size by Country
5.2.1 North America Lyophilized IVIG Sales in Volume by Country (2024-2029)
5.2.2 North America Lyophilized IVIG Sales in Value by Country (2024-2029)
6 Europe Lyophilized IVIG by Country
6.1 Europe Lyophilized IVIG Historic Market Size by Country
6.1.1 Europe Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Lyophilized IVIG Sales in Volume by Country (2018-2023)
6.1.3 Europe Lyophilized IVIG Sales in Value by Country (2018-2023)
6.2 Europe Lyophilized IVIG Forecasted Market Size by Country
6.2.1 Europe Lyophilized IVIG Sales in Volume by Country (2024-2029)
6.2.2 Europe Lyophilized IVIG Sales in Value by Country (2024-2029)
7 Asia-Pacific Lyophilized IVIG by Region
7.1 Asia-Pacific Lyophilized IVIG Historic Market Size by Region
7.1.1 Asia-Pacific Lyophilized IVIG Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Lyophilized IVIG Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Lyophilized IVIG Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Lyophilized IVIG Forecasted Market Size by Region
7.2.1 Asia-Pacific Lyophilized IVIG Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Lyophilized IVIG Sales in Value by Region (2024-2029)
8 Latin America Lyophilized IVIG by Country
8.1 Latin America Lyophilized IVIG Historic Market Size by Country
8.1.1 Latin America Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Lyophilized IVIG Sales in Volume by Country (2018-2023)
8.1.3 Latin America Lyophilized IVIG Sales in Value by Country (2018-2023)
8.2 Latin America Lyophilized IVIG Forecasted Market Size by Country
8.2.1 Latin America Lyophilized IVIG Sales in Volume by Country (2024-2029)
8.2.2 Latin America Lyophilized IVIG Sales in Value by Country (2024-2029)
9 Middle East and Africa Lyophilized IVIG by Country
9.1 Middle East and Africa Lyophilized IVIG Historic Market Size by Country
9.1.1 Middle East and Africa Lyophilized IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Lyophilized IVIG Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Lyophilized IVIG Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Lyophilized IVIG Forecasted Market Size by Country
9.2.1 Middle East and Africa Lyophilized IVIG Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Lyophilized IVIG Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Lyophilized IVIG Products Offered
10.1.5 Takeda Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grifols Lyophilized IVIG Products Offered
10.2.5 Grifols Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Lyophilized IVIG Products Offered
10.3.5 CSL Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Lyophilized IVIG Products Offered
10.4.5 Octapharma Recent Development
10.5 Biotest
10.5.1 Biotest Company Information
10.5.2 Biotest Introduction and Business Overview
10.5.3 Biotest Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biotest Lyophilized IVIG Products Offered
10.5.5 Biotest Recent Development
10.6 Kedrion
10.6.1 Kedrion Company Information
10.6.2 Kedrion Introduction and Business Overview
10.6.3 Kedrion Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kedrion Lyophilized IVIG Products Offered
10.6.5 Kedrion Recent Development
10.7 Hualan Bio
10.7.1 Hualan Bio Company Information
10.7.2 Hualan Bio Introduction and Business Overview
10.7.3 Hualan Bio Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hualan Bio Lyophilized IVIG Products Offered
10.7.5 Hualan Bio Recent Development
10.8 CNBG
10.8.1 CNBG Company Information
10.8.2 CNBG Introduction and Business Overview
10.8.3 CNBG Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CNBG Lyophilized IVIG Products Offered
10.8.5 CNBG Recent Development
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Company Information
10.9.2 Shanghai RAAS Introduction and Business Overview
10.9.3 Shanghai RAAS Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shanghai RAAS Lyophilized IVIG Products Offered
10.9.5 Shanghai RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Introduction and Business Overview
10.10.3 CBPO Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CBPO Lyophilized IVIG Products Offered
10.10.5 CBPO Recent Development
10.11 LFB Group
10.11.1 LFB Group Company Information
10.11.2 LFB Group Introduction and Business Overview
10.11.3 LFB Group Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.11.4 LFB Group Lyophilized IVIG Products Offered
10.11.5 LFB Group Recent Development
10.12 BPL
10.12.1 BPL Company Information
10.12.2 BPL Introduction and Business Overview
10.12.3 BPL Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BPL Lyophilized IVIG Products Offered
10.12.5 BPL Recent Development
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Company Information
10.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview
10.13.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Sichuan Yuanda Shuyang Lyophilized IVIG Products Offered
10.13.5 Sichuan Yuanda Shuyang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lyophilized IVIG Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lyophilized IVIG Industrial Chain Analysis
11.4 Lyophilized IVIG Market Dynamics
11.4.1 Lyophilized IVIG Industry Trends
11.4.2 Lyophilized IVIG Market Drivers
11.4.3 Lyophilized IVIG Market Challenges
11.4.4 Lyophilized IVIG Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lyophilized IVIG Distributors
12.3 Lyophilized IVIG Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
